The University of Central Florida Research Foundation granted RedHill Biopharma development and commercialization rights to a diagnostic to detect Mycobacterium avium paratuberculosis (MAP)

University of Central Florida Research Foundation Inc.

U.S. / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

RedHill Biopharma Ltd.

Israel / Small-Cap Biopharma (<$1 billion)

$34.9m on 09/23/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced